Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | SMN1; SMN2 | Q16637 | 6/20 | 0.56 |
| ▸ | RAB9A | P51151 | 5/20 | 0.56 |
| ▸ | NPC1 | O15118 | 4/20 | 0.56 |
| ▸ | KCNA3 | P22001 | 1/20 | 0.48 |
| ▸ | MAPT | P10636 | 7/20 | 0.48 |
| ▸ | MEN1 | O00255 | 5/20 | 0.48 |
| ▸ | KMT2A | Q03164 | 5/20 | 0.48 |
| ▸ | ALDH1A1 | P00352 | 6/20 | 0.45 |
| ▸ | KDM4E | B2RXH2 | 3/20 | 0.45 |
| ▸ | USP2 | O75604 | 2/20 | 0.45 |
| ▸ | DUSP3 | P51452 | 1/20 | 0.45 |
| ▸ | TDP1 | Q9NUW8 | 1/20 | 0.45 |
| ▸ | ADORA2A | P29274 | 2/20 | 0.42 |
| ▸ | TTR | P02766 | 1/20 | 0.41 |
| ▸ | MAPK1 | P28482 | 5/20 | 0.41 |
| ▸ | CYP3A4 | P08684 | 2/20 | 0.41 |
| ▸ | L3MBTL1 | Q9Y468 | 2/20 | 0.41 |
| ▸ | TSHR | P16473 | 1/20 | 0.41 |
| ▸ | CASP3 | P42574 | 1/20 | 0.41 |
| ▸ | HBB | P68871 | 1/20 | 0.41 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL28643230 | 0.93 | NPC1 (0.55) | SMN1; SMN2RAB9ANPC1KCNA3MAPT | |
| SCHEMBL27584332 | 0.91 | NPC1 (0.54) | SMN1; SMN2RAB9ANPC1KCNA3MAPT | |
| SCHEMBL31690236 | 0.90 | NPC1 (0.52) | SMN1; SMN2RAB9ANPC1KCNA3MAPT | |
| SCHEMBL25223242 | 0.90 | NPC1 (0.52) | SMN1; SMN2RAB9ANPC1KCNA3MAPT | |
| SCHEMBL31690246 | 0.90 | NPC1 (0.52) | SMN1; SMN2RAB9ANPC1KCNA3MAPT | |
| SCHEMBL25216697 | 0.90 | NPC1 (0.52) | SMN1; SMN2RAB9ANPC1KCNA3MAPT | |
| SCHEMBL917515 | 0.90 | NPC1 (0.52) | SMN1; SMN2RAB9ANPC1KCNA3MAPT | |
| SCHEMBL25213837 | 0.90 | NPC1 (0.52) | SMN1; SMN2RAB9ANPC1KCNA3MAPT | |
| SCHEMBL31690241 | 0.90 | NPC1 (0.52) | SMN1; SMN2RAB9ANPC1KCNA3MAPT | |
| SCHEMBL917941 | 0.90 | NPC1 (0.52) | SMN1; SMN2RAB9ANPC1KCNA3MAPT |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 70 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-20260117080-A1 | METAL OXIDE PARTICLES HAVING CORE/SHELL STRUCTURE HAVING UNIFORM PARTICLE SIZE DISTRIBUTION, AND METHOD FOR PRODUCING SAME | NISSAN CHEMICAL CORPORATION (JP) | 2026-04-30 | — | — | US | disclosed |
| US-12606711-B2 | Conductive stannic oxide particle-containing organic solvent-dispersed sol and method of production thereof | NISSAN CHEMICAL CORPORATION (JP) | 2026-04-21 | — | — | US | disclosed |
| US-20250256980-A1 | METAL OXIDE PARTICLE HAVING CORE-SHELL STRUCTURE AND METHOD FOR PRODUCING SAME | NISSAN CHEMICAL CORPORATION (JP) | 2025-08-14 | — | — | US | disclosed |
| US-12359039-B2 | Metal oxide particle-containing composition with reduced occurrence of volatile aldehydes | NISSAN CHEMICAL CORPORATION (JP) | 2025-07-15 | — | — | US | disclosed |
| WO-2025127152-A1 | METAL OXIDE PARTICLES HAVING IMPROVED HYDROPHOBICITY, HIGHLY CONCENTRATED METAL OXIDE SOL, AND METHODS FOR PRODUCING SAME | 日産化学株式会社 | 2025-06-19 | — | — | WO | disclosed |
| CN-119968338-A | Organic solvent sol containing hollow silica particles of amine and method for producing same | 日产化学株式会社 | 2025-05-09 | — | — | CN | disclosed |
| CN-119894824-A | Hollow silica sol containing 1-valent alkali metal ion and method for producing same | 日产化学株式会社 | 2025-04-25 | — | — | CN | disclosed |
| WO-2025084429-A1 | SILICA PARTICLES FOR COATING COMPOSITION AND LAMINATED SUBSTRATE | 日産化学株式会社 | 2025-04-24 | — | — | WO | disclosed |
| EP-4541769-A1 | METAL OXIDE PARTICLE HAVING CORE-SHELL STRUCTURE AND METHOD FOR PRODUCING SAME | Nissan Chemical Corporation (JP) | 2025-04-23 | — | — | EP | disclosed |
| WO-2025069657-A1 | METAL OXIDE PARTICLES WITH COATING AND VARNISH USING SAME | 日産化学株式会社 | 2025-04-03 | — | — | WO | disclosed |
| EP-2641926-A1 | POLYFUNCTIONAL EPOXY COMPOUND | Nissan Chemical Industries, Ltd. (JP) | 2013-09-25 | — | — | EP | disclosed |
| US-8530539-B2 | Curable resin composition for nanoimprint | DAICEL CHEMICAL INDUSTRIES, LTD. (JP) | 2013-09-10 | — | — | US | disclosed |
| US-20130177849-A1 | EPOXY RESIN COMPOSITION HAVING MONOCYCLIC ALIPHATIC HYDROCARBON RING | NISSAN CHEMICAL INDUSTRIES, LTD. (JP) | 2013-07-11 | — | — | US | disclosed |
| EP-2602274-A1 | EPOXY RESIN COMPOSITION HAVING MONOCYCLIC ALIPHATIC HYDROCARBON RING | Nissan Chemical Industries, Ltd. (JP) | 2013-06-12 | — | — | EP | disclosed |
| EP-2530098-A1 | LONG-CHAIN ALKYLENE-CONTAINING CURABLE EPOXY RESIN COMPOSITION | Nissan Chemical Industries, Ltd. (JP) | 2012-12-05 | — | — | EP | disclosed |
| US-20120295199-A1 | LONG-CHAIN ALKYLENE-CONTAINING CURABLE EPOXY RESIN COMPOSITION | NISSAN CHEMICAL INDUSTRIES, LTD. (JP) | 2012-11-22 | — | — | US | disclosed |
| US-20120141738-A1 | CURABLE RESIN COMPOSITION FOR NANOIMPRINT | DAICEL CHEMICAL INDUSTRIES, LTD. (JP) | 2012-06-07 | — | — | US | disclosed |
| US-20110008577-A1 | PROCESS FOR PRODUCTION OF FINE STRUCTURE | DAICEL CHEMICAL INDUSTRIES, LTD. (JP) | 2011-01-13 | — | — | US | disclosed |
| EP-2261007-A1 | PROCESS FOR PRODUCTION OF NANOSTRUCTURES | Daicel Chemical Industries, Ltd. (JP) | 2010-12-15 | — | — | EP | disclosed |
| EP-2246371-A1 | CURABLE RESIN COMPOSITION FOR NANOIMPRINT | Daicel Chemical Industries, Ltd. (JP) | 2010-11-03 | — | — | EP | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20260117080-A1 | METAL OXIDE PARTICLES HAVING CORE/SHELL STRUCTURE HAVING UNIFORM PARTICLE SIZE DISTRIBUTION, AND METHOD FOR PRODUCING SAME | CD63, SLC39A3, ZRANB2 | SMN1; SMN2 1845/4885RAB9A 1398/4885NPC1 1460/4885 |
| US-12606711-B2 | Conductive stannic oxide particle-containing organic solvent-dispersed sol and method of production thereof | SCO2, SOD1, SPOP | SMN1; SMN2 26/4885RAB9A 1071/4885NPC1 124/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.